Bottle Label 4 mg (71610 0355 30)
Tizanidine
Product Images NDC 71610-355
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 71610-355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure-1.jpg (Figure 1)
This is a figure depicting the mean concentration of Tizanidine over time for both tablets and capsules of 2 x 4mg dosage under fasted and fed conditions.*
Figure-2.jpg (Figure 2)
The text describes a figure labeled as "Figure 2" in a single-dose study. The figure displays the mean change in muscle tone from the baseline, as measured by the Ashworth Scale with a 95% confidence interval. A negative Ashworth score indicates an improvement in muscle tone from the baseline. The unit for hours post-dose is also mentioned in the figure.*
Figure-3.jpg (Figure 3)
Chemical-structure (Tizanidine Imtb 01)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
